MZ, K., Y, G., M, C., M, S., I, V., L, O., . . . AM, H. (2026). Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model. International journal of pharmaceutics, 694, 126743. https://doi.org/10.1016/j.ijpharm.2026.126743
Παραπομπή σε μορφή Chicago (17η εκδ.)MZ, Kaya, Gultekin Y, Celebier M, Soyseven M, Vural I, Oner L, Ayata C, Pehlivan SB, και Harriott AM. "Intranasal Hybrid Nanoparticles Encapsulating Rizatriptan Enhance Antimigraine Efficacy in an Optogenetic Spreading Depression Model." International Journal of Pharmaceutics 694 (2026): 126743. https://doi.org/10.1016/j.ijpharm.2026.126743.
Παραπομπή σε μορφή MLA (9th εκδ.)MZ, Kaya, et al. "Intranasal Hybrid Nanoparticles Encapsulating Rizatriptan Enhance Antimigraine Efficacy in an Optogenetic Spreading Depression Model." International Journal of Pharmaceutics, vol. 694, 2026, p. 126743, https://doi.org/10.1016/j.ijpharm.2026.126743.